REFERENCES
- Dinarello CA. Mutations in cryopyrin: bypassing roadblocks in the caspase 1 inflammasome for interleukin-lbeta secretion and disease activity. Arthritis Rheum. 2007;56:2817–22.
- Gattomo M, Tassi S, Carta S, et al. Pattern of interleukin-lbeta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 2007;56:3138–48.
- Aganna E, Martinon F, Hawkins PN, et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensori-neural deafness, and AA amyloidosis. Arthritis Rheum. 2002;46: 2445–52.
- Dodé C, Le Dfi N, Cuisset L, et al. New mutations of CIAS1 that are responsible for Muckle—Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet. 2002;70: 1498–506.
- Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle—Wells syndrome. Nat Genet. 2001;29:301–5.
- Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonu-clear cells and chondrocytes. Am J Hum Genet. 2002;71: 198–203.
- Church LD, McDermott ME Canakinumab, a fully-human mAb against IL- lbeta for the potential treatment of inflammatory disorders. Curr Opin Mol 'Ther. 2009;11:81–9.
- Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360:2416–25.
- Kuemmerle-Deschner JB, Ramos E, Blank N et al.: Canakinumab (ACZ885, a fully human IgG1 anti-IL-1B mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). Arthritis Res 'Ther. 2011;13(1):R34 (Epub ahead of print).
- Kuemmerle-Deschner JB, Hachulla E, Cartwright R, et al. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis. 2011;70(12):2095–102.
- Hoffman HM, Wanderer AA, Broide DH. Familial cold autoin-flammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001;108: 615–20.
- Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med. 1962;31:235–48.
- Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA, Lovell DJ, et al. A chronic, infantile, neurological, cutane-ous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl. 1987;66: 57–68.